Brought to you by

Alexion Pharmaceuticals nets $462.4mm through FOPO
01 Jun 2012
Executive Summary
Alexion Pharmaceuticals Inc. (therapeutics for extremely rare diseases) has netted $462.4mm through the follow-on public offering of 5mm common shares at $93.02.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Large Molecule
- Antibodies
-
Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com